World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
36287
World Ranking
9252
National Ranking
50

Overview

Ingrid Pabinger is affiliated with the Medical University of Vienna in Austria. Their research primarily spans the fields of Medicine, with significant contributions in Hematology, Internal Medicine, Cardiology and Cardiovascular Medicine, Genetics, and Oncology. The focus of their work involves key topics such as Venous Thromboembolism Diagnosis and Management, Hemophilia Treatment and Research, Platelet Disorders and Treatments, Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, Antiplatelet Therapy and Cardiovascular Diseases, and Myeloproliferative Neoplasms: Diagnosis and Treatment.

The scientist's recent notable papers include:

  • Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis, 2020, Research and Practice in Thrombosis and Haemostasis
  • 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19, 2022, The Lancet Oncology
  • Cancer-associated venous thromboembolism, 2022, Nature Reviews Disease Primers
  • Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy, 2020, Blood
  • Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis, 2021, European Heart Journal

Several frequent co-authors have collaborated extensively with Pabinger, including Cihan Ay, Johanna Gebhart, Florian Moik, Stephan Nopp, and Oliver Königsbrügge.

Ingrid Pabinger has published frequently in several scientific venues, with the highest numbers of publications appearing in:

  • Hämostaseologie (43 publications)
  • Research and Practice in Thrombosis and Haemostasis (38 publications)
  • Journal of Thrombosis and Haemostasis (25 publications)
  • Blood (20 publications)
  • Thrombosis Research (15 publications)

Their research output demonstrates a comprehensive engagement with various aspects of thrombotic disorders, hemostasis, and cardiovascular medicine, reflecting a multidisciplinary approach within clinical and translational research.

Best Publications

  • Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    Shannon M. Bates;Ian A. Greer;Ingrid Pabinger;Shoshanna Sofaer

  • Increased fetal loss in women with heritable thrombophilia

    FE Preston;FR Rosendaal;ID Walker;E Briët

  • Prediction of venous thromboembolism in cancer patients

    Cihan Ay;Daniela Dunkler;Christine Marosi;Alexandru-Laurentiu Chiriac

  • International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    D Farge;P Debourdeau;M Beckers;C Baglin

  • D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

    Cihan Ay;Rainer Vormittag;Daniela Dunkler;Ralph Simanek

  • Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

    Johnny Mahlangu;Jerry S. Powell;Margaret V. Ragni;Pratima Chowdary

  • Wilson's disease in patients presenting with liver disease: A diagnostic challenge

    P Steindl;P Ferenci;H P Dienes;G Grimm

  • 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

    Dominique Farge;Dominique Farge;Corinne Frere;Jean M Connors;Cihan Ay

  • High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

    Cihan Ay;Ralph Simanek;Rainer Vormittag;Daniela Dunkler

  • Romiplostim or standard of care in patients with immune thrombocytopenia.

    David J. Kuter;Mathias Rummel;Ralph Boccia;B. Gail Macik

  • Cancer-associated venous thromboembolism: Burden, mechanisms, and management

    Cihan Ay;Ingrid Pabinger;Alexander T. Cohen

  • A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

    Damla Olcaydu;Ashot Harutyunyan;Roland Jäger;Tiina Berg

  • High D-dimer levels are associated with poor prognosis in cancer patients

    Cihan Ay;Daniela Dunkler;Robert Pirker;Johannes Thaler

  • Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis.

    Stephan Nopp;Florian Moik;Bernd Jilma;Ingrid Pabinger

  • International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Dominique Farge;Henri Bounameaux;Benjamin Brenner;Francis Cajfinger

  • Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.

    I. Pabinger;B. Brenner;U. Kalina;S. Knaub

  • International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.

    P Debourdeau;D Farge;M Beckers;C Baglin

  • The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study.

    B. De Laat;V. Pengo;I. Pabinger;J. Musial

  • Hyperhomocysteinemia Is a Risk Factor of Recurrent Venous Thromboembolism

    S. Eichinger;A. Stümpflen;M. Hirschl;C. Bialonczyk

  • INCREASED FETAL LOSS IN WOMEN WITH HERITABLE THROMBOPHILIA

    F. E. Preston;F. R. Rosendaal;I. D. Walker;E. Briet

Frequent Co-Authors

Klaus Lechner
Klaus Lechner Medical University of Vienna
Christine Mannhalter
Christine Mannhalter Medical University of Vienna
Christoph C. Zielinski
Christoph C. Zielinski Medical University of Vienna
Bernd Jilma
Bernd Jilma Medical University of Vienna
Alok A. Khorana
Alok A. Khorana Cleveland Clinic
Matthias Preusser
Matthias Preusser Medical University of Vienna
Francesco Rodeghiero
Francesco Rodeghiero Yamagata University
Johannes Oldenburg
Johannes Oldenburg University of Bonn
Ajay K. Kakkar
Ajay K. Kakkar University College London
Henri Bounameaux
Henri Bounameaux University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, you're not limited to the traditional MD path. Today, numerous 3 year online pharmd programs allow students to become pharmacists through flexible, accelerated options. These programs are ideal for those who want to fast-track their entry into pharmaceutical practice while balancing work or family commitments.

For those interested in managing patient data and health records, accredited online him programs can pave the way to careers in health information management. These roles are vital for the efficient running of hospitals and clinics.

Another growing field is medical billing and coding, which provides opportunities to work remotely while supporting healthcare administration. The average cost of medical billing and coding program is often much lower than that of traditional clinical degrees, making it an accessible entry point into healthcare.

Finally, for registered nurses looking to advance, the most affordable nurse practitioner programs can help you move into advanced practice roles with a focus on patient care, autonomy, and leadership.

Best Scientists Citing Ingrid Pabinger

Trending Scientists

Recently Published Articles